Skip to main content
. Author manuscript; available in PMC: 2018 Jan 15.
Published in final edited form as: Int J Cardiol. 2016 Nov 4;227:462–466. doi: 10.1016/j.ijcard.2016.11.006

Fig. 1.

Fig. 1

Love plot displaying absolute standardized differences for 34 baseline characteristics of hospitalized patients with heart failure and reduced ejection fraction receiving and not receiving spironolactone, before and after propensity score matching (ACE=angiotensin-converting enzyme; ARB=angiotensin receptor blockers)